Angiotech Pharma launches Tan EndoGlide Endothelium Insertion System
Angiotech Pharmaceuticals, Inc. has launched the Tan EndoGlide(TM) Endothelium Insertion System in the United States. Angiotech holds exclusive U.S. distribution rights to market and distribute the Tan EndoGlide Endothelium Insertion System. The Tan EndoGlide is a device used to facilitate insertion of a donor endothelium during Endothelial Keratoplasty. The device is used by Ophthalmologists adapting to newer techniques to replace diseased corneal endothelium.
- Sun Pharma gets FDA nod for generic Tessalon
- Aurobindo Pharma receive tentative approval for generic Alzheimer`s drug
- Astellas and XenoPort Announce Submission of a New Drug Application in Japan
- Sandoz launches generic Antizol
